Alteration status and prognostic value of MET in head and neck squamous cell carcinoma
The MET pathway plays a key role in various cancers, and its inhibition represents a potential treatment target. However, appropriate biomarkers are needed to facilitate the selection of patients who would benefit from MET inhibiting therapy. We herein conducted a robust confirmatory evaluation of t...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Ivyspring International Publisher
2016
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5166528/ |